IL105319A - History of hydrazide of 3,4-dihydro-H2-1-benzopyrans and their pharmaceutical preparations - Google Patents

History of hydrazide of 3,4-dihydro-H2-1-benzopyrans and their pharmaceutical preparations

Info

Publication number
IL105319A
IL105319A IL105319A IL10531993A IL105319A IL 105319 A IL105319 A IL 105319A IL 105319 A IL105319 A IL 105319A IL 10531993 A IL10531993 A IL 10531993A IL 105319 A IL105319 A IL 105319A
Authority
IL
Israel
Prior art keywords
compounds
alkyl
compound
dihydro
hydroxy
Prior art date
Application number
IL105319A
Other languages
English (en)
Hebrew (he)
Other versions
IL105319A0 (en
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of IL105319A0 publication Critical patent/IL105319A0/xx
Publication of IL105319A publication Critical patent/IL105319A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • C07D311/72—3,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/66—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL105319A 1992-04-07 1993-04-05 History of hydrazide of 3,4-dihydro-H2-1-benzopyrans and their pharmaceutical preparations IL105319A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92400972 1992-04-07

Publications (2)

Publication Number Publication Date
IL105319A0 IL105319A0 (en) 1993-08-18
IL105319A true IL105319A (en) 1998-02-22

Family

ID=8211648

Family Applications (1)

Application Number Title Priority Date Filing Date
IL105319A IL105319A (en) 1992-04-07 1993-04-05 History of hydrazide of 3,4-dihydro-H2-1-benzopyrans and their pharmaceutical preparations

Country Status (19)

Country Link
EP (1) EP0635011B1 (de)
JP (1) JP3226174B2 (de)
KR (1) KR950700680A (de)
AT (1) ATE146466T1 (de)
AU (1) AU675784B2 (de)
CA (1) CA2132831C (de)
DE (1) DE69306770T2 (de)
DK (1) DK0635011T3 (de)
ES (1) ES2098730T3 (de)
FI (1) FI944678A0 (de)
GR (1) GR3022122T3 (de)
HU (1) HU215912B (de)
IL (1) IL105319A (de)
MX (1) MX9301979A (de)
NO (1) NO943760L (de)
NZ (1) NZ251174A (de)
TW (1) TW278076B (de)
WO (1) WO1993020059A1 (de)
ZA (1) ZA932414B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721233A (en) * 1992-04-06 1998-02-24 Merrell Pharmaceuticals Inc. Derivatives of 2,3-dihydro benzofuranols
US5510373A (en) * 1992-04-06 1996-04-23 Merrell Pharmaceuticals Inc. Cardioprotective agents
US5451603A (en) * 1993-03-11 1995-09-19 Zymogenetics, Inc. 3,4-diarylchromans for treatment of dermatitis
US5416098A (en) * 1993-12-30 1995-05-16 Zymogenetics, Inc. Method for treating dermatitis and related conditions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3010505A1 (de) * 1980-03-19 1981-10-01 Basf Ag, 6700 Ludwigshafen Chromanderivate, verfahren zu ihrer herstellung, ihre verwendung als stabilisatoren von organischen materialien sowie diese stabilisatoren enthaltende organische materialien
CA1338012C (en) * 1987-04-27 1996-01-30 John Michael Mccall Pharmaceutically active amines
EP0369083A1 (de) * 1988-11-14 1990-05-23 Merrell Dow Pharmaceuticals Inc. Herzschutz-Tocopherolanaloge
EP0412939A3 (en) * 1989-08-11 1991-09-04 Ciba-Geigy Ag Certain benzopyran and benzothiopyran derivatives
DE4000397A1 (de) * 1990-01-09 1991-07-11 Hoechst Ag Lipidselektive antioxidantien sowie deren herstellung und verwendung
KR900016822A (ko) * 1990-04-20 1990-11-14 하라 레이노스께 슬라이드 프로젝터

Also Published As

Publication number Publication date
ATE146466T1 (de) 1997-01-15
CA2132831C (en) 1998-06-16
DE69306770T2 (de) 1997-06-12
GR3022122T3 (en) 1997-03-31
DK0635011T3 (da) 1997-01-06
HU215912B (hu) 1999-03-29
ES2098730T3 (es) 1997-05-01
HU9402882D0 (en) 1995-01-30
AU675784B2 (en) 1997-02-20
FI944678A (fi) 1994-10-06
HUT68833A (en) 1995-08-28
CA2132831A1 (en) 1993-10-14
FI944678A0 (fi) 1994-10-06
MX9301979A (es) 1993-11-01
KR950700680A (ko) 1995-02-20
JP3226174B2 (ja) 2001-11-05
DE69306770D1 (de) 1997-01-30
ZA932414B (en) 1993-10-22
WO1993020059A1 (en) 1993-10-14
AU3807293A (en) 1993-11-08
NO943760D0 (no) 1994-10-06
JPH07505625A (ja) 1995-06-22
EP0635011B1 (de) 1996-12-18
NZ251174A (en) 1996-01-26
IL105319A0 (en) 1993-08-18
NO943760L (no) 1994-12-06
EP0635011A1 (de) 1995-01-25
TW278076B (de) 1996-06-11

Similar Documents

Publication Publication Date Title
JP3230699B2 (ja) 心臓保護トコフェロ−ル類似体
JP3066901B2 (ja) 心臓保護トコフェロール類似体
US5484810A (en) Tissue protective tocopherol analogs
US5545660A (en) Hydrazide derivatives of 3,4-dihydro-2H-1-benzopyrans
US5750516A (en) Phosphoric diester
EP0635011B1 (de) Hydrazid-derivate von 3,4-dihydro-2h-1-benzopyranen
JP3246741B2 (ja) ２，３−ジヒドロベンゾフラノールの新規な誘導体及びその製法
CA2132745C (en) Novel cardioprotective agents
JPH11501655A (ja) ２，３−ジヒドロ−ベンゾフラノール誘導体の新規な製造法
US5500444A (en) Cardioprotective tocopherol analogs
US5510373A (en) Cardioprotective agents
EP0369083A1 (de) Herzschutz-Tocopherolanaloge
EP0369082A1 (de) Herzschutz-Tocopherolanaloge

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
RH1 Patent not in force